SEC Form 4 · accession 0001209191-16-118249
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles O Holliday Jr.
Director
Period of report
May 4, 2016
Accepted (ET)
May 6, 2016 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 4, 2016 | P | 4,000 | $79.6822 | A | 8,000 | D | |
| Common Stock | May 4, 2016 | A | 2,192 | $0.00 | A | 10,192 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.655 to $79.69, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2Represents common stock underlying 2,192 restricted share units which shall vest on the sooner of the date of the Issuer's 2017 annual shareholders' meeting or the first anniversary of the grant date.